Mood and Cognitive Effects of Psilocybin in Healthy Participants

Clinical trial NCT05252598 · WITHDRAWN

Trial details

NCT number: NCT05252598
Sponsor: Optimi Health Corporation
Status: WITHDRAWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Mood Disturbance Mood Change Sleep Disturbance Drug Effect Psychedelic Experiences Health, Subjective Psilocin Toxicity Psilocybin Toxicity Psilocybin Causing Adverse Effects in Therapeutic Use Anxiety

Start date: 2023-01-01
Primary completion: 2023-08-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.